Literature DB >> 15527809

Surveillance of patients at high risk for colorectal cancer.

Sapna Syngal1, Prathap Bandipalliam, C Richard Boland.   

Abstract

Colorectal cancer (CRC) mortality may be greatly reduced by clinically feasible screening programs. The benefits of surveillance of high-risk programs are evident. Cancer mortality can be dramatically reduced by eradication of precursor lesions and by detection of cancer at an early and highly curable stage. Available screening methods, recommended intervals, and screening for other associated cancers are reviewed for specific high-risk groups.

Entities:  

Mesh:

Year:  2005        PMID: 15527809     DOI: 10.1016/j.mcna.2004.08.013

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  3 in total

1.  Clement Richard Boland, Jr., MD: a conversation with the editor. Interview by William Clifford Roberts.

Authors:  Clement Richard Boland
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

2.  Exome sequencing in one family with gastric- and rectal cancer.

Authors:  Jessada Thutkawkorapin; Simone Picelli; Vinaykumar Kontham; Tao Liu; Daniel Nilsson; Annika Lindblom
Journal:  BMC Genet       Date:  2016-02-13       Impact factor: 2.797

3.  Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group.

Authors:  Rachel P Riechelmann; Rui F Weschenfelder; Frederico P Costa; Aline Chaves Andrade; Alessandro Bersch Osvaldt; Ana Rosa P Quidute; Allan Dos Santos; Ana Amélia O Hoff; Brenda Gumz; Carlos Buchpiguel; Bruno S Vilhena Pereira; Delmar Muniz Lourenço Junior; Duilio Reis da Rocha Filho; Eduardo Antunes Fonseca; Eduardo Linhares Riello Mello; Fabio Ferrari Makdissi; Fabio Luiz Waechter; Francisco Cesar Carnevale; George B Coura-Filho; Gustavo Andrade de Paulo; Gustavo Colagiovanni Girotto; João Evangelista Bezerra Neto; João Glasberg; Jose Claudio Casali-da-Rocha; Juliana Florinda M Rego; Luciana Rodrigues de Meirelles; Ludhmila Hajjar; Marcos Menezes; Marcello D Bronstein; Marcelo Tatit Sapienza; Maria Candida Barisson Villares Fragoso; Maria Adelaide Albergaria Pereira; Milton Barros; Nora Manoukian Forones; Paulo Cezar Galvão do Amaral; Raphael Salles Scortegagna de Medeiros; Raphael L C Araujo; Regis Otaviano França Bezerra; Renata D'Alpino Peixoto; Samuel Aguiar; Ulysses Ribeiro; Tulio Pfiffer; Paulo M Hoff; Anelisa K Coutinho
Journal:  Ecancermedicalscience       Date:  2017-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.